These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26463642)

  • 21. Belatacept: a novel immunosuppressive agent for kidney transplant recipients.
    Charpentier B
    Expert Rev Clin Immunol; 2012 Nov; 8(8):719-28. PubMed ID: 23167683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of topical ciclosporin 0.05% for prevention of rejection in high-risk corneal grafts.
    Unal M; Yücel I
    Br J Ophthalmol; 2008 Oct; 92(10):1411-4. PubMed ID: 18662913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental study on the effect of cyclosporine A drug delivery system implanted in anterior chamber on high-risk corneal graft rejection.
    Xie L; Shi W; Wang Z; Liu Z
    Zhonghua Yan Ke Za Zhi; 2002 Jul; 38(7):422-5. PubMed ID: 12411004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclosporine nanomicelle eye drop: a novel medication for corneal graft transplantation treatment.
    Zhang H; Wang L; Zhang L
    Biol Pharm Bull; 2015; 38(6):893-900. PubMed ID: 26027830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Combined rapamycin eye drop in nanometer vector and poly (lactic acid) wafers of cyclosporine A effectively prevents high-risk corneal allograft rejection in rabbits].
    Jiang W; Sun HM; Li XR; Yuan XB; Wang YQ; Zhang SX; Tian EJ; Yuan JQ
    Zhonghua Yan Ke Za Zhi; 2009 Jun; 45(6):550-5. PubMed ID: 19957680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunological aspects of corneal graft rejection and own experience in immunosuppressive therapy in high risk patients].
    Kamińska A; Szaflik J; Minkiewicz-Timler G; Sybilska M; Pawluczyk-Dyjecińska M; Smolarek M
    Klin Oczna; 2004; 106(3 Suppl):485-8. PubMed ID: 15636244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy of topical cyclosporine A on keratoplasty rejection in rats].
    Zhang W; Pan Z; Zhai C
    Zhonghua Yan Ke Za Zhi; 2001 Mar; 37(2):140-3. PubMed ID: 11864411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Animal models of high-risk corneal transplantation: A comprehensive review.
    Singh RB; Marmalidou A; Amouzegar A; Chen Y; Dana R
    Exp Eye Res; 2020 Sep; 198():108152. PubMed ID: 32721424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcineurin inhibitors in pediatric renal transplant recipients.
    Filler G
    Paediatr Drugs; 2007; 9(3):165-74. PubMed ID: 17523697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective randomized study of azathioprine vs cyclosporine based therapy in primary haplo-identical living-donor kidney transplantation: 20-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
    Clin Exp Nephrol; 2007 Jun; 11(2):151-155. PubMed ID: 17593515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
    Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M
    Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunosuppression in corneal transplantation].
    Scheer S; Touzeau O; Borderie V; Laroche L
    J Fr Ophtalmol; 2003 Jun; 26(6):637-47. PubMed ID: 12910207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of cyclosporine in lung transplantation.
    Parekh K; Trulock E; Patterson GA
    Transplant Proc; 2004 Mar; 36(2 Suppl):318S-322S. PubMed ID: 15041361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunosuppression in corneal transplantation.
    Hill JC
    Eye (Lond); 1995; 9 ( Pt 2)():247-53. PubMed ID: 7556726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Term Outcomes of High-Risk Keratoplasty in Patients Receiving Systemic Immunosuppression.
    Chow SP; Cook SD; Tole DM
    Cornea; 2015 Nov; 34(11):1395-9. PubMed ID: 26382894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B
    Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of cyclosporine in renal transplantation.
    Hesselink DA; Smak Gregoor PJ; Weimar W
    Transplant Proc; 2004 Mar; 36(2 Suppl):99S-106S. PubMed ID: 15041316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcome after early cyclosporine withdrawal in kidney transplantation: ten years after.
    Tabibzadeh N; Glowacki F; Frimat M; Elsermans V; Provôt F; Lionet A; Gnemmi V; Hertig A; Noël C; Hazzan M
    Clin Transplant; 2016 Nov; 30(11):1480-1487. PubMed ID: 27623348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lessons from cyclosporine monotherapy in renal transplantation: the impact of acute rejection on long-term allograft outcome.
    Coll E; Crespo M; Solé M; Campistol JM; Cofàn F; Esforzado N; Ricart MJ; Torregrosa JV; Oppenheimer F
    Transplant Proc; 2004 Mar; 36(2 Suppl):114S-116S. PubMed ID: 15041318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.